APPLIED THERAPEUTICS, INC.

Analyst Reco. Applied Therapeutics, Inc.

Equities

APLT

US03828A1016

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
4.76 ^USD	+5.08%		+11.21%	+42.09%

15/04	Applied Therapeutics, Inc. Announces Management Changes	CI
28/03	Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Initiates Applied Therapeutics at Outperform, Speculative Risk With $12 Price Target, Sees Lead Drug Govorestat 'Well-Positioned for Success'	26/03	MT
UBS Adjusts Applied Therapeutics Price Target to $13 From $12, Maintains Buy Rating	15/03	MT
UBS Adjusts Applied Therapeutics Price Target to $12 From $4, Maintains Buy Rating	06/03	MT
Leerink Partners Initiates Applied Therapeutics at Outperform Rating $12 Price Target	22/02	MT
S&P 500, Nasdaq climb as fresh data boosts rate-cut bets again	05/01	RE
US job data raises doubts about the Fed's next moves	05/01
Waning Rate Cut Hopes, Employment Situation Report Push Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	05/01	MT
Baird Adjusts Applied Therapeutics Price Target to $14 From $18, Maintains Outperform Rating	25/23/25	MT
Citigroup Adjusts Applied Therapeutics Price Target to $5 From $23, Maintains Buy Rating	05/23/05	MT
Citigroup Cuts Price Target on Applied Therapeutics to $23 From $29, Keeps Buy Rating	17/22/17	MT
Citigroup Adjusts Applied Therapeutics' Price Target to $29 from $30, Keeps Buy Rating	20/22/20	MT
Truist Securities Adjusts Price Target on Applied Therapeutics to $6 From $85, Reiterates Buy Rating	13/22/13	MT
Barclays Adjusts Price Target on Applied Therapeutics to $2.50 From $7, Keeps Equalweight Rating	21/22/21	MT
Citigroup Adjusts Applied Therapeutics' Price Target to $30 From $38, Reiterates Buy Rating	05/22/05	MT
Goldman Sachs Adjusts Price Target on Applied Therapeutics to $3 From $10, Reiterates Sell Rating	05/22/05	MT
Barclays Downgrades Applied Therapeutics to Equalweight From Overweight, Slashes Price Target to $7 From $44	04/22/04	MT
APPLIED THERAPEUTICS : Goldman Sachs Cuts Applied Therapeutics to Sell From Neutral, Price Target to $10 From $16	27/21/27	MT
APPLIED THERAPEUTICS : UBS Adjusts Price Target on Applied Therapeutics to $48 From $67 on Adjusted AT-001, AT-007 Timelines; Buy Rating Kept	02/21/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer